Chetan Lathia

5.6k citations
53 papers · 4.4k indexed · 3 hit papers · h-index 24
Topics
Colorectal Cancer Treatments and Studies (10 papers)Melanoma and MAPK Pathways (9 papers)Lung Cancer Treatments and Mutations (9 papers)

In The Last Decade

Chetan Lathia

51 papers receiving 4.3k citations

Hit Papers

Phase II Study of Sorafenib in Patients With Advanced Hep...2006202620122019200620092012250500750

Peers

Chetan Lathia
Comparison fields: 5 of 103
  • Molecular Biology 2.0k
  • Oncology 1.6k
  • Pulmonary and Respiratory Medicine 1.5k
  • Hepatology 1.3k
  • Cancer Research 1.2k
Replace Ferry A.L.M. Eskens with:
Ferry A.L.M. Eskens Netherlands
Vincenzo Catalano Italy
Sergio Ricci Italy
Erika Martinelli Italy
Frank Cihon United States
Alexander Laird United States
재연 정
Christopher R. Garrett United States
Rafael G. Amado United States
D. Voliotis Germany
Chetan Lathia relative to Ferry A.L.M. Eskens Netherlands Ferry A.L.M. Eskens's profile →
Citations per field
00.5×1.5×1.9×
Ferry A.L.M. Eskens · 1×
Citations per year

Countries citing papers authored by Chetan Lathia

Since Specialization
Citations

This map shows the geographic impact of Chetan Lathia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chetan Lathia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chetan Lathia more than expected).

Fields of papers citing papers by Chetan Lathia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chetan Lathia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chetan Lathia. The network helps show where Chetan Lathia may publish in the future.

Co-authorship network of co-authors of Chetan Lathia

This figure shows the co-authorship network connecting the top 25 collaborators of Chetan Lathia. A scholar is included among the top collaborators of Chetan Lathia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chetan Lathia. Chetan Lathia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 20
2 18
3 43
4 16
5
Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trialbreakdown →
864
6 28
7 45
8 256
9 25
10 4
11 5
12 6
13 6
14 46
15 9
16 1
17 102
18 0
19 1
20 9

About Chetan Lathia

Chetan Lathia is a scholar working on Oncology, Hepatology and Cancer Research, having authored 53 papers that have together received 4.4k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (10 papers), Melanoma and MAPK Pathways (9 papers) and Lung Cancer Treatments and Mutations (9 papers). The work is most often cited by research in Hepatology (1.3k citations), Cancer Research (1.2k citations) and Oncology (1.6k citations). Chetan Lathia has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Brian Schwartz, Carol E. Peña, Armando Santoro, M. Moscovici, Jacques De Grève, Arié Figer, Sergio Ricci, Dino Amadori, Ghassan K. Abou‐Alfa and Jordi Bruix. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026